Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.

Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.

Item
http://www.wikidata.org/entity/Q35776408
Exocrine drainage in vascularized pancreas transplantation in the new millenniumRapamycin promotes Schwann cell migration and nerve growth factor secretion.Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas-Kidney Transplants.Early Kidney Allograft Dysfunction (Threatened Allograft): Comparative Effectiveness of Continuing Versus Discontinuation of Tacrolimus and Use of Sirolimus to Prevent Graft Failure: A Retrospective Patient-Centered Outcome Study.Evidence for rapamycin toxicity in pancreatic β-cells and a review of the underlying molecular mechanisms.Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective.Type 2 diabetes: is pancreas transplantation an option?Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions.Lessons From Pancreas Transplantation in Type 1 Diabetes: Recurrence of Islet Autoimmunity.Biomarkers in pancreas transplant.mTOR inhibitors in pancreas transplant: adverse effects and drug-drug interactions.Successful treatment for graft-versus-host disease after pancreas transplantation.
P2860

Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.

Item
http://www.wikidata.org/entity/Q35776408
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Advantage of rapamycin over my ...... ngle-center trial at 10 years.
@ast
Advantage of rapamycin over my ...... ngle-center trial at 10 years.
@en
type
label
Advantage of rapamycin over my ...... ngle-center trial at 10 years.
@ast
Advantage of rapamycin over my ...... ngle-center trial at 10 years.
@en
prefLabel
Advantage of rapamycin over my ...... ngle-center trial at 10 years.
@ast
Advantage of rapamycin over my ...... ngle-center trial at 10 years.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Advantage of rapamycin over my ...... ngle-center trial at 10 years.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1600-6143.2012.04235.X
P407
P433
P478
P577
P5875
P698
P921
P932